Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01776307
Title A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications

colorectal cancer

Therapies

Cetuximab + Napabucasin

Capecitabine + Napabucasin

Napabucasin + Panitumumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.